Deal Highlights

Guided Cryoport, Inc. during its acquisition of CRYOPDP Group, at a purchase price of approximately EUR49 million

Cryoport, Inc., a leading global provider of temperature-controlled supply chain solutions for life sciences, acquired CRYOPDP Group in 2020 for approximately EUR49 million. CRYOPDP specializes in temperature-sensitive logistics solutions for the life sciences industry, with operations in over 150 countries. The acquisition enabled Cryoport to enhance its logistics services for cellular therapies, vaccines, and clinical trials globally. Majmudar & Partners advised on the legal aspects of the deal, especially in respect of Cryoport’s regulatory obligations and compliances in India.

Facilitating the Transaction

Majmudar & Partners provided legal advisory services to Cryoport to ensure smooth legal compliance throughout the acquisition process. Key contributions included:

  • Due Diligence: Conducted comprehensive due diligence on CRYOPDP’s Indian operations, ensuring that the Indian company was compliant with local regulations, taxation, and employee-related laws.
  • Regulatory Compliance: Assisted in navigating  Indian foreign exchange regulations, the Companies Act, and other relevant local laws applicable to the life sciences industry to ensure smooth execution of the transaction.
  • Post-Acquisition Integration: Supported Cryoport in legally integrating CRYOPDP’s Indian operations into its global supply chain, ensuring all post-acquisition corporate filings and regulatory compliances were fulfilled.
  • Contract Drafting and Negotiation: Drafted and negotiated critical contracts including share purchase agreements and employment contracts for CRYOPDP’s Indian employees, ensuring that Cryoport’s interests were safeguarded.

Cryoport’s acquisition of CRYOPDP Group was a strategic move that strengthened its position as a global leader in temperature-sensitive logistics for the life sciences industry. By expanding its reach and capabilities, Cryoport became better equipped to meet the growing demands of the biopharma and clinical trials markets in India. Majmudar & Partners provided essential legal guidance, ensuring compliance with Indian regulations and supporting the smooth integration of CRYOPDP’s operations into Cryoport’s global network.

With extensive experience in handling cross-border M&A transactions, Majmudar & Partners is well-positioned to provide expert legal advice to companies looking to expand their operations in India and globally. Contact us today to learn how we can support your business in navigating complex M&A transactions and ensuring regulatory compliance.